Beyond the ISCHEMIA Trial: Revascularization for Stable Ischemic Heart Disease in Patients With High‐Risk Coronary Anatomical Features

por Bergmark, Brian A., Morrow, David A.
Publicado 2020

Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers

por Tokgozoglu, Lale, Morrow, David A, Nicholls, Stephen J
Publicado 2023

Blood pressure and oxygenation targets after out-of-hospital cardiac arrest-trial (BOX)( )

por van Diepen, Sean, Tavazzi, Guido, Morrow, David A
Publicado 2022

Respiratory support in acute heart failure with preserved vs reduced ejection fraction

por Metkus, Thomas S., Stephens, Robert Scott, Schulman, Steven, Hsu, Steven, Morrow, David A., Eid, Shaker M.
Publicado 2019

Dynamic TIMI Risk Score for STEMI

por Amin, Sameer T., Morrow, David A., Braunwald, Eugene, Sloan, Sarah, Contant, Charles, Murphy, Sabina, Antman, Elliott M.
Publicado 2013

ECG Morphological Variability in Beat Space for Risk Stratification After Acute Coronary Syndrome

por Liu, Yun, Syed, Zeeshan, Scirica, Benjamin M., Morrow, David A., Guttag, John V., Stultz, Collin M.
Publicado 2014

Percutaneous right ventricular assist device–supported ventricular tachycardia ablation in a patient with severe right ventricular dysfunction

por Aguilar, Martin, Tsao, Allison L., Croce, Kevin J., Sauer, William, Morrow, David A., Tedrow, Usha B.
Publicado 2019

COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies

por Atri, Deepak, Siddiqi, Hasan K., Lang, Joshua P., Nauffal, Victor, Morrow, David A., Bohula, Erin A.
Publicado 2020

Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry

por Bhatt, Ankeet S., Daniels, Lori B., de Lemos, James, Goodrich, Erica, Bohula, Erin A., Morrow, David A.
Publicado 2023

A current review of COVID-19 for the cardiovascular specialist

por Lang, Joshua P., Wang, Xiaowen, Moura, Filipe A., Siddiqi, Hasan K., Morrow, David A., Bohula, Erin A.
Publicado 2020

Effect of Ranolazine on A1C and Glucose Levels in Hyperglycemic Patients With Non-ST Elevation Acute Coronary Syndrome

por Chisholm, Jeffrey W., Goldfine, Allison B., Dhalla, Arvinder K., Braunwald, Eugene, Morrow, David A., Karwatowska-Prokopczuk, Ewa, Belardinelli, Luiz
Publicado 2010

Biomarker of Collagen Turnover (C‐Terminal Telopeptide) and Prognosis in Patients With Non‐ST‐Elevation Acute Coronary Syndromes

por Zelniker, Thomas A., Jarolim, Petr, Scirica, Benjamin M., Braunwald, Eugene, Park, Jeong‐Gun, Das, Saumya, Sabatine, Marc S., Morrow, David A.
Publicado 2019

Practice pattern of use of high sensitivity troponin in the outpatient settings

por Ferro, Enrico G., Bhatt, Ankeet S., Zhou, Guohai, Fiumara, Karen, Wasfy, Jason H., Sequist, Thomas D., Morrow, David A., Scirica, Benjamin M.
Publicado 2020

Efficacy and Safety of Vorapaxar by Intensity of Background Lipid‐Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P‐TIMI 50 Trial

por Gilchrist, Ian C., Morrow, David A., Creager, Mark A., Olin, Jeffrey W., Scirica, Benjamin M., Goodrich, Erica L., Bonaca, Marc P.
Publicado 2021

Plasma Omega‐3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN‐TIMI 36

por Zelniker, Thomas A., Morrow, David A., Scirica, Benjamin M., Furtado, Jeremy D., Guo, Jianping, Mozaffarian, Dariush, Sabatine, Marc S., O’Donoghue, Michelle L.
Publicado 2021

Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P‐TIMI 50

por Berg, David D., Freedman, Benjamin L., Bonaca, Marc P., Jarolim, Petr, Scirica, Benjamin M., Goodrich, Erica L., Sabatine, Marc S., Morrow, David A.
Publicado 2021

Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P‐TIMI 50 trial

por Freedman, Benjamin L., Berg, David D., Scirica, Benjamin M., Bohula, Erin A., Goodrich, Erica L., Sabatine, Marc S., Morrow, David A., Bonaca, Marc P.
Publicado 2023

Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis: Observations from the Dallas Heart Study

por Lindsey, Jason B., de Lemos, James A., Cipollone, Francesco, Ayers, Colby R., Rohatgi, Anand, Morrow, David A., Khera, Amit, McGuire, Darren K.
Publicado 2009

Care Setting Intensity and Outcomes After Emergency Department Presentation Among Patients With Acute Heart Failure

por Goldraich, Livia, Austin, Peter C., Zhou, Limei, Tu, Jack V., Schull, Michael J., Mak, Susanna, Ross, Heather J., Morrow, David A., Lee, Douglas S.
Publicado 2016

Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome

por Correa, Simon, Morrow, David A., Braunwald, Eugene, Davies, Richard Y., Goodrich, Erica L., Murphy, Sabina A., Cannon, Christopher P., O'Donoghue, Michelle L.
Publicado 2018